市場調査レポート

商品コード

1560976

家禽用ワクチン市場レポート：疾患別、製品別、投与形態別、用途別、エンドユーザー別、地域別、2024年～2032年

Poultry Vaccines Market Report by Disease, Product, Dosage Form, Application, End User, and Region 2024-2032

出版日: 2024年09月10日
発行: IMARC
ページ情報: 英文 145 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF & Excel (Single User License)

USD 2,999 447,900円

レポートPDFおよびExcelを1名のみがご利用頂けるライセンスです。PDFおよびExcelの印刷は一度のみ可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (5 User License)

USD 3,999 597,250円

レポートPDFおよびExcelを同一企業内の5名様までがご利用頂けるライセンスです。PDFおよびExcelの印刷は可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Corporate License)

USD 4,999 746,600円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等の編集は可能ですが、事前にIMARC Services Private Limited社の許可が必要です。PDFおよびExcelの印刷回数に制限はありません。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=149.35円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の家禽用ワクチン市場の市場規模は2023年に19億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに32億米ドルに達し、2024年から2032年の間に5.6％の成長率（CAGR）を示すと予測しています。家禽の疾病予防に対する意識の高まり、安全で疾病のない家禽製品に対する需要の増加、持続可能な生産を確保するためのワクチン開発における継続的な技術進歩が、市場成長を促進する主な要因です。

家禽用ワクチンは、鶏、アヒル、ターキーなどの家禽を感染症から守るために特別に設計された生物学的製品です。鳥の免疫反応を誘発し、ウイルスや細菌を含む特定の病原体に対する免疫の発達を可能にするよう処方されます。ワクチン接種は、注射、エアゾール、鳥の飲み水など、さまざまな経路で行うことができます。ワクチン接種プログラムは、その地域で流行している特定の疾病リスクに合わせてカスタマイズされ、養鶏場におけるバイオセキュリティ対策の不可欠な一部となっています。さらに農家は、適切な家禽ワクチンを利用することで、疾病の発生を効果的に緩和し、家禽製品の持続可能で安全な生産を確保することができます。今日、家禽用ワクチンは家禽集団の健康と福祉を維持するために不可欠です。

市場は主に、生物学的製品に対する需要の高まりによって牽引されています。加えて、食肉や卵を含む家禽製品への需要の高まりが家禽生産の増加につながり、市場成長に影響を及ぼしています。これに伴い、家禽個体数の増加により、家禽を保護し生産レベルを維持するためのワクチン使用が必要となり、市場成長に寄与しています。さらに、養鶏農家や生産者の間で、群れの健康や生産性を確保するためのワクチン接種を含む予防医療措置の重要性に対する認識が高まっていることも、成長を促す大きな要因となっています。これとともに、ワクチン接種は、感染症の蔓延を抑制・予防し、抗生物質やその他の治療の必要性を減少させる、費用対効果の高い効率的な方法であると考えられており、市場の成長を促進しています。これに加えて、食品の安全性と動物福祉の重要性を強調するいくつかの政府政策の実施が、市場の成長を加速させています。さらに、ワクチン技術と研究の進歩により、より効果的で標的を絞ったワクチンが開発され、その有効性と安全性プロファイルが改善されたため、市場の見通しは明るいです。

家禽用ワクチン市場動向/促進要因：

鶏肉消費の増加

鶏肉、食肉、卵などの鶏肉製品に対する需要の高まりが市場成長に影響を与えています。加えて、人口の増加、急速な都市化、個人の多忙なライフスタイルが鶏肉製品の需要を高めており、市場成長に寄与しています。さらに、養鶏農家は、家禽の群れを保護し、病気のない安全な製品を安定供給するための予防措置としてワクチン接種を行うようになっており、これも市場成長を促す大きな要因となっています。これに加えて、ワクチンは家禽を伝染病から守る効果的かつ効率的な方法を提供し、伝染病の発生とそれに伴う生産損失の可能性を減少させるため、市場の成長を加速させる。これとともに、農家は家禽の群れに予防接種を行うことで、家禽の健康と生産性を向上させ、養鶏産業の効率性と収益性の改善につなげることができるため、市場の成長を促進します。これとは別に、家禽消費の増加は家禽と家禽製品の国際貿易の増加につながり、市場成長を促進しています。

疾病予防に関する意識の高まり

家禽個体群における感染症の発生が増加しているため、農家や生産者は自分たちの群れを守るための予防措置を実施するためにワクチンを広く採用するようになり、市場成長に影響を与えています。さらに、農家は、投資を保護し、疾病を制御し、家禽の感染症の発生率と重症度を下げるために、ワクチン接種プログラムに投資するようになってきており、これも成長を促す大きな要因となっています。これに加えて、農家は家禽の群れに予防接種を行うことで、疾病の蔓延を防ぎ、生産ロスを最小限に抑え、消費者の需要に応える健康な家禽製品の安定供給を確保することができるため、市場の成長が加速します。これとともに、健康志向の高まりと安全で高品質な食品への需要の高まりが、ワクチンの助けを借りて安全で健全な鶏肉製品の生産に貢献しており、市場成長を促進しています。さらに、ワクチンを接種した家禽の利点に関する消費者の意識の高まりが、家禽用ワクチンの需要をさらに押し上げ、生産者にワクチン接種を疾病予防戦略の重要な側面として優先させるよう促しています。

ワクチン開発における新たな技術的進歩

最新のワクチンの開拓により、有効性が向上し、免疫力がより長く持続するワクチンの生産が可能になり、数多くの家禽疾病に対するより優れた防御が提供されるため、市場の成長に寄与しています。さらに、バイオテクノロジーの継続的な発展、革新的なアプローチ、技術により、より効果的で安全な、標的を絞った家禽用ワクチンが開発されつつあり、これも成長を促す大きな要因となっています。これに加えて、アジュバントやベクターベースのワクチンなど、ワクチン送達システムの広範な進歩により、家禽用ワクチンはより強固で特異的な免疫反応を引き起こすことができるようになり、市場の成長を加速させています。これに加え、こうしたブレークスルーは、様々な家禽種や地域の疾病課題に特有のニーズに対応できるカスタマイズワクチンの開発につながり、市場成長を後押ししています。さらに、ワクチン製剤の進歩により、より安定した耐熱性ワクチンが開発され、保存性が向上し、コールドチェーンでの保管や輸送の必要性が減少したことで、特に遠隔地や資源が乏しい地域の養鶏農家へのワクチンの配布や入手が容易になり、市場の見通しが明るくなりました。

北米
- 米国
- カナダ
アジア太平洋地域
- 中国
- 日本
- インド
- 韓国
- オーストラリア
- インドネシア
- その他
欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- ロシア
- その他
ラテンアメリカ
- ブラジル
- メキシコ
- その他
中東・アフリカ
- 市場動向
- 市場内訳：国別
- 市場予測

第12章 SWOT分析

概要
強み
弱み
機会
脅威

第13章バリューチェーン分析

第14章ポーターのファイブフォース分析

概要
買い手の交渉力
供給企業の交渉力
競合の程度
新規参入業者の脅威
代替品の脅威

第15章価格分析

第16章競合情勢

市場構造
主要企業
主要企業のプロファイル
- AniCon Labor GmbH（SAN Group）
- Biovac Ltd.
- Boehringer Ingelheim International GmbH
- Ceva Sante Animale
- Elanco
- Hester Biosciences Limited
- Merck & Co. Inc.
- Phibro Animal Health Corporation
- Venkys India
- Zoetis Inc.

図表

List of Figures

Figure 1: Global: Poultry Vaccines Market: Major Drivers and Challenges
Figure 2: Global: Poultry Vaccines Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Poultry Vaccines Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Poultry Vaccines Market: Breakup by Disease (in %), 2023
Figure 5: Global: Poultry Vaccines Market: Breakup by Product (in %), 2023
Figure 6: Global: Poultry Vaccines Market: Breakup by Dosage Form (in %), 2023
Figure 7: Global: Poultry Vaccines Market: Breakup by Application (in %), 2023
Figure 8: Global: Poultry Vaccines Market: Breakup by End User (in %), 2023
Figure 9: Global: Poultry Vaccines Market: Breakup by Region (in %), 2023
Figure 10: Global: Poultry Vaccines (Infectious Bronchitis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Poultry Vaccines (Infectious Bronchitis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Poultry Vaccines (Avian Influenza) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Poultry Vaccines (Avian Influenza) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Poultry Vaccines (Newcastle Disease) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Poultry Vaccines (Newcastle Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Poultry Vaccines (Marek's Disease) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Poultry Vaccines (Marek's Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Poultry Vaccines (Other Diseases) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Poultry Vaccines (Other Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Poultry Vaccines (Recombinant Vaccine) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Poultry Vaccines (Recombinant Vaccine) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Poultry Vaccines (Live Attenuated Vaccine) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Poultry Vaccines (Live Attenuated Vaccine) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Poultry Vaccines (Inactivated Vaccine) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Poultry Vaccines (Inactivated Vaccine) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Poultry Vaccines (Subunit Vaccine) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Poultry Vaccines (Subunit Vaccine) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Poultry Vaccines (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Poultry Vaccines (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Poultry Vaccines (Liquid Vaccine) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Poultry Vaccines (Liquid Vaccine) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Global: Poultry Vaccines (Freeze Dried Vaccine) Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: Poultry Vaccines (Freeze Dried Vaccine) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Global: Poultry Vaccines (Breeder) Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Global: Poultry Vaccines (Breeder) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Global: Poultry Vaccines (Broiler) Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Global: Poultry Vaccines (Broiler) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Global: Poultry Vaccines (Layer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Global: Poultry Vaccines (Layer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Global: Poultry Vaccines (Veterinary Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Global: Poultry Vaccines (Veterinary Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Global: Poultry Vaccines (Poultry Firm) Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Global: Poultry Vaccines (Poultry Firm) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Global: Poultry Vaccines (Poultry Vaccination Center) Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Global: Poultry Vaccines (Poultry Vaccination Center) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: North America: Poultry Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: North America: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: United States: Poultry Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: United States: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Canada: Poultry Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Canada: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Asia-Pacific: Poultry Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Asia-Pacific: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: China: Poultry Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: China: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Japan: Poultry Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Japan: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: India: Poultry Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: India: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: South Korea: Poultry Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: South Korea: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Australia: Poultry Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Australia: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Indonesia: Poultry Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Indonesia: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Others: Poultry Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Others: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Europe: Poultry Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Europe: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Germany: Poultry Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Germany: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: France: Poultry Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: France: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: United Kingdom: Poultry Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: United Kingdom: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Italy: Poultry Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Italy: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Spain: Poultry Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Spain: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Russia: Poultry Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 81: Russia: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 82: Others: Poultry Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 83: Others: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 84: Latin America: Poultry Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 85: Latin America: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 86: Brazil: Poultry Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 87: Brazil: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 88: Mexico: Poultry Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 89: Mexico: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 90: Others: Poultry Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 91: Others: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 92: Middle East and Africa: Poultry Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 93: Middle East and Africa: Poultry Vaccines Market: Breakup by Country (in %), 2023
Figure 94: Middle East and Africa: Poultry Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 95: Global: Poultry Vaccines Industry: SWOT Analysis
Figure 96: Global: Poultry Vaccines Industry: Value Chain Analysis
Figure 97: Global: Poultry Vaccines Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Poultry Vaccines Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Poultry Vaccines Market Forecast: Breakup by Disease (in Million US$), 2024-2032
Table 3: Global: Poultry Vaccines Market Forecast: Breakup by Product (in Million US$), 2024-2032
Table 4: Global: Poultry Vaccines Market Forecast: Breakup by Dosage Form (in Million US$), 2024-2032
Table 5: Global: Poultry Vaccines Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 6: Global: Poultry Vaccines Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 7: Global: Poultry Vaccines Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 8: Global: Poultry Vaccines Market: Competitive Structure
Table 9: Global: Poultry Vaccines Market: Key Players

Product Code: SR112024A4547

The global poultry vaccines market size reached US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5.6% during 2024-2032. The growing awareness of disease prevention among poultry, the increasing demand for safe and disease-free poultry products, and the continuous technological advancements in vaccine development to ensure sustainable production are major factors driving the market growth.

Poultry vaccines are biological products specifically designed to protect domestic birds, such as chickens, ducks, and turkeys, from infectious diseases. It is formulated to trigger an immune response in birds, enabling them to develop immunity against specific pathogens, including viruses and bacteria. The vaccination process can be administered through different routes, such as injection, aerosol, or in the drinking water of the birds. Vaccination programs are customized to the specific disease risks prevalent in a region, and they are an integral part of biosecurity measures on poultry farms. Additionally, farmers can effectively mitigate disease outbreaks and ensure the sustainable and safe production of poultry products, by utilizing appropriate poultry vaccines. Nowadays, poultry vaccines are essential in maintaining the health and welfare of poultry populations.

The market is primarily driven by the rising demand for biological products. In addition, the escalating demand for poultry products, including meat and eggs led to increased poultry production, thus influencing the market growth. In line with this, the growing poultry populations are necessitating the use of vaccines to protect the birds and maintain production levels, thus contributing to market growth. Moreover, the growing awareness among poultry farmers and producers about the importance of preventive healthcare measures, including vaccination, to ensure the well-being and productivity of their flocks represents another major growth-inducing factor. Along with this, vaccination is considered a cost-effective and efficient method to control and prevent the spread of infectious diseases, reducing the need for antibiotics and other treatments, thus propelling market growth. Besides this, the implementation of several government policies emphasizing the importance of food safety and animal welfare are accelerating the market growth. Furthermore, advancements in vaccine technology and research led to the development of more effective and targeted vaccines, improving their efficacy and safety profiles, thus creating a positive market outlook.

Poultry Vaccines Market Trends/Drivers:

The increasing poultry consumption

The rising demand for poultry products, such as chicken, meat, and eggs is influencing the market growth. In addition, the growing population, rapid urbanization, busy lifestyles of individuals are escalating the demand for poultry products, thus contributing to the market growth. Moreover, poultry farmers are turning to vaccination as a preventive measure to protect their flocks and ensure a steady supply of safe and disease-free products representing another major growth-inducing factor. Besides this, vaccines offer an effective and efficient way to protect poultry from infectious diseases, reducing the likelihood of outbreaks and associated production losses, thus accelerating market growth. Along with this, farmers can enhance bird health and productivity, leading to improved efficiency and profitability in the poultry industry by immunizing their flocks, thus propelling market growth. Apart from this, the rising poultry consumption has led to increased international trade of poultry and poultry products, thus propelling market growth.

The growing awareness regarding disease prevention

The growing incidences of infectious diseases in poultry populations are resulting in the widespread adoption of vaccines by farmers and producers to implement preventive measures to protect their flocks, thus influencing market growth. Moreover, farmers are increasingly investing in vaccination programs to safeguard their investments, control disease, and help reduce the incidence and severity of infectious diseases in poultry representing another major growth-inducing factor. Besides this, farmers can prevent disease spread and minimize production losses, ensuring a consistent supply of healthy poultry products to meet consumer demands by immunizing their flocks, thus accelerating market growth. Along with this, the increasing health-conscious and escalating demand for safe and high-quality food products is contributing to the production of safe and wholesome poultry products with the help of vaccines, thus propelling market growth. Furthermore, the growing awareness among consumers about the benefits of vaccinated poultry further drives the demand for poultry vaccines, encouraging producers to prioritize vaccination as a critical aspect of their disease prevention strategies.

The emerging technological advancements in vaccine development

The development of modern vaccines allows the production of vaccines with improved efficacy and longer-lasting immunity, providing better protection against numerous poultry diseases, thus contributing to market growth. Moreover, the continuous development in biotechnology, innovative approaches, and techniques are leading to the creation of more effective, safe, and targeted poultry vaccines representing another major growth-inducing factor. Besides this, the extensive advancements in vaccine delivery systems, such as adjuvants and vector-based vaccines, poultry vaccines can now trigger a more robust and specific immune response thus accelerating the market growth. Along with this, these breakthroughs led to the development of customized vaccines that can address the specific needs of various poultry species and regional disease challenges, thus propelling market growth. Furthermore, advancements in vaccine formulation led to the creation of more stable and temperature-tolerant vaccines, enhancing their shelf life and reducing the need for cold chain storage and transportation leading to easier distribution and accessibility of vaccines to poultry farmers, especially in remote or resource-constrained regions, thus creating a positive market outlook.

Poultry Vaccines Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global poultry vaccines market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on disease, product, dosage form, application, and end user.

Breakup by Disease:

Infectious Bronchitis
Avian Influenza
Newcastle Disease
Marek's Disease
Others

Newcastle disease represents the most common disease

The report has provided a detailed breakup and analysis of the market based on the disease. This includes infectious bronchitis, avian influenza, newcastle disease, marek's disease, and others. According to the report, Newcastle disease accounted for the largest market share.

Newcastle disease (ND) is a highly contagious viral disease that affects various avian species, including chickens, turkeys, and pigeons, leading to severe economic losses in the poultry industry. In addition, newcastle disease is a primary concern for poultry farmers and producers due to rapid transmission and devastating impact on poultry flocks, thus influencing the market growth. Also, outbreaks of ND can result in high mortality rates, reduced egg production, and decreased feed conversion efficiency, leading to substantial financial losses for the poultry industry, thus augmenting market growth. Along with this, vaccination is essential for preventive measures for poultry producers, to help build immunity against the virus, reduce the severity of infections, and minimize the spread of the disease among flocks, thus propelling the market growth. Besides this, the regular and timely vaccination of poultry populations is essential to protect against ND outbreaks and maintain flock health, thus accelerating market growth. Apart from this, poultry farmers are relying on these vaccines to ensure the well-being of their flocks, secure their investments, and maintain a steady supply of disease-free poultry products to meet consumer demands, thus providing a positive thrust to the market growth.

Breakup by Product:

Recombinant Vaccine
Live Attenuated Vaccine
Inactivated Vaccine
Subunit Vaccine
Others

Live attenuated vaccine represents the most popular product

The report has provided a detailed breakup and analysis of the market based on the product. This includes recombinant vaccine, live attenuated vaccine, inactivated vaccine, subunit vaccine, and others. According to the report, live attenuated vaccines accounted for the largest market share.

Live attenuated vaccines are developed from weakened forms of pathogens that retain their ability to induce an immune response in the host without causing severe disease, thus contributing to market growth. Additionally, live attenuated vaccines have superior efficacy in providing long-lasting immunity against numerous poultry diseases, thus influencing market growth. These vaccines elicit humoral and cell-mediated immune responses, offering robust protection to poultry flocks. Moreover, live attenuated vaccines mimic natural infections, leading to a comprehensive and sustained immune defense, and can address several poultry diseases, including avian influenza, Newcastle disease, and infectious bronchitis representing another major growth-inducing factor. Besides this, live attenuated vaccines' ability to confer cross-protection against different strains of pathogens adds to their appeal among poultry farmers and producers, thus accelerating the market growth. Apart from their efficacy, live attenuated vaccines are generally cost-effective, making them an attractive choice for large-scale poultry production, thus propelling the market growth.

Breakup by Dosage Form:

Liquid Vaccine
Freeze Dried Vaccine

Liquid vaccine presently accounts for the largest market share

The report has provided a detailed breakup and analysis of the market based on the dosage form. This includes liquid vaccines and freeze-dried vaccines. According to the report, liquid vaccine accounted for the largest market share.

Liquid vaccines are known for their ease of administration and can be delivered through drinking water or by subcutaneous or intramuscular injection, making the vaccination process more straightforward and efficient. In addition, the ease of administration is particularly essential when vaccinating large flocks, as it minimizes the time and effort required for vaccination procedures, thus augmenting the market growth. Moreover, liquid vaccines offer better homogeneity and consistency in dosing, which are well-mixed in the vaccine solution, ensuring that each bird receives an accurate and uniform dose of the vaccine representing another major growth-inducing factor. This consistency is essential for achieving optimal immunization levels across the entire poultry population and maximizing the vaccine's efficacy.

Besides this, liquid vaccines can be more cost-effective than other dosage forms, as it involves lower manufacturing costs, and their efficient administration reduces the need for specialized equipment or additional labor, further accelerating the market growth. Furthermore, the convenience and reliability of liquid vaccines are contributing to their widespread adoption in the poultry industry as poultry farmers seek practical solutions to protect their flocks from diseases thus creating a positive market outlook.

Breakup by Application:

Breeder
Broiler
Layer

Broiler holds the leading position in the market

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes breeder, broiler, and layer. According to the report, broilers accounted for the largest market share.

Broilers are chickens that are specifically raised for meat production thus accelerating the market growth. In addition, the escalating demand for broiler meat due to its affordability, versatility, and nutritional value is contributing to the market growth. As the global population continues to grow, there is a higher need for efficient and sustainable protein sources, making broiler meat an attractive option for consumers and food industries. Moreover, the intensive nature of broiler farming, with large-scale commercial production, necessitates a strong focus on disease prevention and biosecurity representing another major growth-inducing factor. Along with this, broilers raised in confined spaces are more susceptible to infectious diseases due to high stocking densities, making vaccination an essential aspect of their health management is propelling the market growth. Besides this, broilers have a shorter production cycle compared to other poultry species, such as layers (egg-laying hens). This means that a larger number of broilers are produced and processed within a shorter timeframe, leading to an escalating demand for poultry vaccines to protect these birds from potential disease outbreaks that could impact production and profitability, thus creating a positive market outlook.

Breakup by End User:

Veterinary Hospitals
Poultry Firm
Poultry Vaccination Center

A detailed breakup and analysis of the market based on the end-user has also been provided in the report. This includes veterinary hospitals, poultry firm, and poultry vaccination center.

Veterinary hospitals are essential in the distribution and administration of poultry vaccines. They are essential in providing medical care and advice to poultry farmers and producers. In addition, they offer expertise in diagnosing diseases, prescribing suitable vaccines, and administering vaccinations to poultry flocks, thus contributing to the market growth. These establishments act as trusted sources of information and are pivotal in promoting the adoption of vaccination practices among poultry farmers.

Moreover, poultry firms, including commercial poultry farms and integrated poultry companies, are significant consumers of poultry vaccines. These firms manage large-scale poultry operations and are highly invested in ensuring the health and productivity of their flocks. Along with this, vaccination is an integral part of their disease prevention and biosecurity strategies, as it helps protect the entire poultry population from infectious diseases, thus providing a positive thrust to the market growth. Poultry firms procure vaccines in bulk to immunize their vast flocks and minimize the risk of disease outbreaks that could lead to substantial production losses, thus influencing the market growth.

Besides this, poultry vaccination centers are specialized facilities dedicated to administering vaccines to poultry. These centers may be operated by private entities or government agencies. They cater to the needs of small-scale poultry farmers and backyard poultry keepers who may not have access to veterinary hospitals or lack expertise in vaccination procedures, thus accelerating the market growth. Poultry vaccination centers provide convenient access to vaccines, offer vaccination services, and assist in implementing proper vaccination schedules to ensure the health and well-being of the birds.

Breakup by Region:

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America is driven by the presence of advanced poultry farming practices, robust biosecurity measures, and a high level of awareness about disease prevention among poultry farmers, thus influencing market growth. In addition, the United States and Canada are the major contributors to the escalating demand for poultry vaccines, as these countries boast well-established poultry industries with a focus on modern production techniques and stringent biosecurity standards, thus accelerating market growth. Moreover, the widespread adoption of advanced vaccination programs is essential in protecting poultry flocks from infectious diseases, ensuring a continuous and reliable supply of poultry products to meet consumer demands, representing another major growth-inducing factor.

Besides this, in Europe market, countries such as the United Kingdom, Germany, France, and the Netherlands have well-developed poultry industries that prioritize disease prevention through vaccination, thus augmenting market growth. Along with this, in the Asia Pacific market, countries such as China, India, and Brazil are witnessing substantial growth in poultry production and consumption. As these regions experience an increase in poultry farming activities, there is a growing demand for poultry vaccines to mitigate disease risks and ensure the health and productivity of poultry flocks, thus creating a positive market outlook.

Competitive Landscape:

Nowadays, key players in the market are implementing various strategies to strengthen their position and gain a competitive edge in the industry. They are investing in research and development (R&D) to develop advanced and more effective poultry vaccines and exploring new technologies and innovative approaches to enhance vaccine efficacy, safety, and duration of immunity. Moreover, companies are forming strategic collaborations and partnerships with other industry stakeholders, such as research institutions, universities, and poultry associations, allowing companies to stay at the forefront of vaccine development and stay ahead of the competition. Besides this, key players are catering to a broader range of poultry diseases and species and expanding their product portfolios by introducing new vaccines targeting specific pathogens and adopting a more personalized approach to address regional disease challenges.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

AniCon Labor GmbH (SAN Group) Biovac Ltd.
Boehringer Ingelheim International GmbH
Ceva Sante Animale
Elanco
Hester Biosciences Limited
Merck & Co. Inc.
Phibro Animal Health Corporation
Venkys India
Zoetis Inc.

Recent Developments:

In January 2020, Boehringer Ingelheim International GmbH introduced the VAXXITEK HVT+IBD+ND vaccine to protect poultry against Newcastle disease, Marek's disease, and infectious bursal disease (classic and variant types). They produce VAXXITEK HVT+IBD+ND from its site which develops more than 60 billion doses of poultry vaccine a year for use in the U.S. and over 60 other countries.
In October 2022, Zoetis Inc. launched Poulvac Procerta HVT-IBD-ND, a recombinant vector vaccine that offers early/robust protection against infectious bursal, Marek's, and Newcastle disease viruses with one dose, while expanding its poultry vaccine portfolio.
In April 2022, Elanco, in collaboration with Ginkgo Bioworks, introduced a new animal healthcare company called BiomEdit to develop nutritional products, drugs, and disease-monitoring methods for livestock which aim to address antibiotic resistance and improve sustainability.

Key Questions Answered in This Report

1. What was the size of the global poultry vaccines market in 2023?
2. What is the expected growth rate of the global poultry vaccines market during 2024-2032?
3. What has been the impact of COVID-19 on the global poultry vaccines market?
4. What are the key factors driving the global poultry vaccines market?
5. What is the breakup of the global poultry vaccines market based on the disease?
6. What is the breakup of the global poultry vaccines market based on the product?
7. What is the breakup of the global poultry vaccines market based on the dosage form?
8. What is the breakup of the global poultry vaccines market based on the application?
9. What are the key regions in the global poultry vaccines market?
10. Who are the key players/companies in the global poultry vaccines market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Poultry Vaccines Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Disease

6.1 Infectious Bronchitis
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Avian Influenza
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Newcastle Disease
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Marek's Disease
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
6.5 Others
- 6.5.1 Market Trends
- 6.5.2 Market Forecast

7 Market Breakup by Product

7.1 Recombinant Vaccine
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Live Attenuated Vaccine
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Inactivated Vaccine
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Subunit Vaccine
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast

8 Market Breakup by Dosage Form

8.1 Liquid Vaccine
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Freeze Dried Vaccine
- 8.2.1 Market Trends
- 8.2.2 Market Forecast

9 Market Breakup by Application

9.1 Breeder
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Broiler
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Layer
- 9.3.1 Market Trends
- 9.3.2 Market Forecast

10 Market Breakup by End User

10.1 Veterinary Hospitals
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
10.2 Poultry Firm
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
10.3 Poultry Vaccination Center
- 10.3.1 Market Trends
- 10.3.2 Market Forecast

11 Market Breakup by Region

11.1 North America
- 11.1.1 United States
  - 11.1.1.1 Market Trends
  - 11.1.1.2 Market Forecast
- 11.1.2 Canada
  - 11.1.2.1 Market Trends
  - 11.1.2.2 Market Forecast
11.2 Asia-Pacific
- 11.2.1 China
  - 11.2.1.1 Market Trends
  - 11.2.1.2 Market Forecast
- 11.2.2 Japan
  - 11.2.2.1 Market Trends
  - 11.2.2.2 Market Forecast
- 11.2.3 India
  - 11.2.3.1 Market Trends
  - 11.2.3.2 Market Forecast
- 11.2.4 South Korea
  - 11.2.4.1 Market Trends
  - 11.2.4.2 Market Forecast
- 11.2.5 Australia
  - 11.2.5.1 Market Trends
  - 11.2.5.2 Market Forecast
- 11.2.6 Indonesia
  - 11.2.6.1 Market Trends
  - 11.2.6.2 Market Forecast
- 11.2.7 Others
  - 11.2.7.1 Market Trends
  - 11.2.7.2 Market Forecast
11.3 Europe
- 11.3.1 Germany
  - 11.3.1.1 Market Trends
  - 11.3.1.2 Market Forecast
- 11.3.2 France
  - 11.3.2.1 Market Trends
  - 11.3.2.2 Market Forecast
- 11.3.3 United Kingdom
  - 11.3.3.1 Market Trends
  - 11.3.3.2 Market Forecast
- 11.3.4 Italy
  - 11.3.4.1 Market Trends
  - 11.3.4.2 Market Forecast
- 11.3.5 Spain
  - 11.3.5.1 Market Trends
  - 11.3.5.2 Market Forecast
- 11.3.6 Russia
  - 11.3.6.1 Market Trends
  - 11.3.6.2 Market Forecast
- 11.3.7 Others
  - 11.3.7.1 Market Trends
  - 11.3.7.2 Market Forecast
11.4 Latin America
- 11.4.1 Brazil
  - 11.4.1.1 Market Trends
  - 11.4.1.2 Market Forecast
- 11.4.2 Mexico
  - 11.4.2.1 Market Trends
  - 11.4.2.2 Market Forecast
- 11.4.3 Others
  - 11.4.3.1 Market Trends
  - 11.4.3.2 Market Forecast
11.5 Middle East and Africa
- 11.5.1 Market Trends
- 11.5.2 Market Breakup by Country
- 11.5.3 Market Forecast

12 SWOT Analysis

12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
- 16.3.1 AniCon Labor GmbH (SAN Group)
  - 16.3.1.1 Company Overview
  - 16.3.1.2 Product Portfolio
- 16.3.2 Biovac Ltd.
  - 16.3.2.1 Company Overview
  - 16.3.2.2 Product Portfolio
- 16.3.3 Boehringer Ingelheim International GmbH
  - 16.3.3.1 Company Overview
  - 16.3.3.2 Product Portfolio
- 16.3.4 Ceva Sante Animale
  - 16.3.4.1 Company Overview
  - 16.3.4.2 Product Portfolio
- 16.3.5 Elanco
  - 16.3.5.1 Company Overview
  - 16.3.5.2 Product Portfolio
  - 16.3.5.3 Financials
- 16.3.6 Hester Biosciences Limited
  - 16.3.6.1 Company Overview
  - 16.3.6.2 Product Portfolio
  - 16.3.6.3 Financials
- 16.3.7 Merck & Co. Inc.
  - 16.3.7.1 Company Overview
  - 16.3.7.2 Product Portfolio
  - 16.3.7.3 Financials
  - 16.3.7.4 SWOT Analysis
- 16.3.8 Phibro Animal Health Corporation
  - 16.3.8.1 Company Overview
  - 16.3.8.2 Product Portfolio
  - 16.3.8.3 Financials
  - 16.3.8.4 SWOT Analysis
- 16.3.9 Venkys India
  - 16.3.9.1 Company Overview
  - 16.3.9.2 Product Portfolio
- 16.3.10 Zoetis Inc.
  - 16.3.10.1 Company Overview
  - 16.3.10.2 Product Portfolio
  - 16.3.10.3 Financials
  - 16.3.10.4 SWOT Analysis

家禽用ワクチン市場レポート：疾患別、製品別、投与形態別、用途別、エンドユーザー別、地域別、2024年～2032年

Poultry Vaccines Market Report by Disease, Product, Dosage Form, Application, End User, and Region 2024-2032

家禽用ワクチン市場動向/促進要因：

目次

第1章 序文

第2章 調査範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の家禽用ワクチン市場

第6章 市場内訳：疾患別

第7章 市場内訳：製品別

第8章 市場内訳：投与形態別

第9章 市場内訳：用途別

第10章 市場内訳：エンドユーザー別

第11章 市場内訳：地域別

第12章 SWOT分析

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

第15章 価格分析

第16章 競合情勢